VRTX Related Major News
-
Vertex Pharmaceuticals, Inc. (VRTX) Tops Q1 EPS by 21c
-
Vertex Pharmaceuticals, Inc. (VRTX) Posts Q4 EPS of 4c; Guides FY13 Sales
-
Vertex Pharmaceuticals, Inc. (VRTX) Misses Q3 EPS by 6c
-
Vertex Pharmaceuticals, Inc. (VRTX) Misses Q2 EPS by 13c; Revises Revenues
-
Vertex Pharmaceuticals, Inc. (VRTX) Misses Q1 EPS by 11c
-
Vertex Pharmaceuticals, Inc. (VRTX) Tops Q4 EPS by 16c
-
Vertex Pharmaceuticals, Inc. (VRTX) Blows Up Q3 Estimates
-
Vertex Pharmaceuticals, Inc. (VRTX) Reports Q2 Loss of 85c, Beats by 10c
-
Vertex Pharmaceuticals Incorporated (VRTX) Tops Q1 EPS by 11c
-
FDA Panel Backs Vertex Pharmaceuticals (VRTX) Telaprevir
-
Vertex Pharmaceuticals (VRTX) Tops Q4 Views
-
Vertex Pharma (VRTX) Reports Q3 Adj-Loss of 87c, Beats by 5c; Reaffirms Guidance
-
Vertex Pharmaceuticals (VRTX) Reports Smaller Q2 Loss; Highlights Clinical Progress
-
Vertex Pharma (VRTX) Posts Q1 non-GAAP Loss of $0.70, Beats Views; Reiterates FY10 Guidance
-
Vertex Pharma (VRTX) Reports Better-Than-Expected Q4 Loss of $0.66
-
Vertex Pharma (VRTX) Reports Better-Than-Expected Q3 Loss of $0.71; Reiterates FY09 Outlook
-
Vertex Pharma (VRTX) Reports In-Line Q1 Loss of $0.82
-
Vertex Pharmaceuticals (VRTX) Reports Mixed Q4 Results
-
Vertex (VRTX) Founder Dr. Boger Retires As President/CEO Replaced By Emmens
-
Vertex Pharmaceuticals (VRTX) Reports Mixed Q2 Earnings
-
Vertex Pharmaceuticals (VRTX) Reports Q1 Loss of $0.61
-
Vertex Pharmaceuticals (VRTX) Reports Q4 Loss of $0.66
Back to VRTX Stock Lookup
